These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 19209619)
1. Insulin resistance, obesity, hypofibrinolysis, hyperandrogenism, and coronary heart disease risk factors in 25 pre-perimenarchal girls age < or =14 years, 13 with precocious puberty, 23 with a first-degree relative with polycystic ovary syndrome. Glueck CJ; Morrison JA; Wang P J Pediatr Endocrinol Metab; 2008 Oct; 21(10):973-84. PubMed ID: 19209619 [TBL] [Abstract][Full Text] [Related]
2. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents. Glueck CJ; Morrison JA; Friedman LA; Goldenberg N; Stroop DM; Wang P Metabolism; 2006 Apr; 55(4):508-14. PubMed ID: 16546482 [TBL] [Abstract][Full Text] [Related]
3. [Polycystic ovary syndrome in pubertal period: clinical, biological, metabolic and genetic polymorphism]. Trimèche S; Thuan Dit Dieudonne JF; Jeandel C; Paris F; Simoni-Brum I; Orio F; Sultan C Gynecol Obstet Fertil; 2004 Jan; 32(1):3-17. PubMed ID: 14736594 [TBL] [Abstract][Full Text] [Related]
4. Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome. Alemzadeh R; Kichler J; Calhoun M Eur J Endocrinol; 2010 Jun; 162(6):1093-9. PubMed ID: 20371657 [TBL] [Abstract][Full Text] [Related]
5. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome]. Li X; Lin JF Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817 [TBL] [Abstract][Full Text] [Related]
6. Atherogenic metabolic profile in PCOS patients: role of obesity and hyperandrogenism. Castelo-Branco C; Steinvarcel F; Osorio A; Ros C; Balasch J Gynecol Endocrinol; 2010 Oct; 26(10):736-42. PubMed ID: 20569105 [TBL] [Abstract][Full Text] [Related]
8. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. Yildiz BO; Yarali H; Oguz H; Bayraktar M J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950 [TBL] [Abstract][Full Text] [Related]
9. [Exploration of the classification of polycystic ovarian syndrome]. Lin JF; Li X; Zhu MW Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924 [TBL] [Abstract][Full Text] [Related]
11. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2. Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ; Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102 [TBL] [Abstract][Full Text] [Related]
12. Raised plasminogen activator inhibitor-1 (PAI-1) is not an independent risk factor in the polycystic ovary syndrome (PCOS). Atiomo WU; Fox R; Condon JE; Shaw S; Friend J; Prentice AG; Wilkin TJ Clin Endocrinol (Oxf); 2000 Apr; 52(4):487-92. PubMed ID: 10762292 [TBL] [Abstract][Full Text] [Related]
13. Coronary heart disease risk factors in adult premenopausal white women with polycystic ovary syndrome compared with a healthy female population. Glueck CJ; Morrison JA; Goldenberg N; Wang P Metabolism; 2009 May; 58(5):714-21. PubMed ID: 19375597 [TBL] [Abstract][Full Text] [Related]
14. Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women. Möhlig M; Weickert MO; Ghadamgadai E; Machlitt A; Pfüller B; Arafat AM; Pfeiffer AF; Schöfl C Eur J Endocrinol; 2007 Aug; 157(2):195-200. PubMed ID: 17656598 [TBL] [Abstract][Full Text] [Related]
15. Functional ovarian hyperandrogenism and polycystic ovary syndrome in prepubertal girls with obesity and/or premature pubarche. Siklar Z; Oçal G; Adiyaman P; Ergur A; Berberoğlu M J Pediatr Endocrinol Metab; 2007 Apr; 20(4):475-81. PubMed ID: 17550211 [TBL] [Abstract][Full Text] [Related]
16. Association of MEP1A gene variants with insulin metabolism in central European women with polycystic ovary syndrome. Lam UD; Lerchbaum E; Schweighofer N; Trummer O; Eberhard K; Genser B; Pieber TR; Obermayer-Pietsch B Gene; 2014 Mar; 537(2):245-52. PubMed ID: 24388959 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the pro-inflammatory cytokine tumor necrosis factor-α in adolescents with polycystic ovary syndrome. Pawelczak M; Rosenthal J; Milla S; Liu YH; Shah B J Pediatr Adolesc Gynecol; 2014 Dec; 27(6):356-9. PubMed ID: 25256873 [TBL] [Abstract][Full Text] [Related]
18. Dyslipidaemia in polycystic ovarian syndrome: different groups, different aetiologies? Meirow D; Raz I; Yossepowitch O; Brzezinski A; Rosler A; Schenker JG; Berry EM Hum Reprod; 1996 Sep; 11(9):1848-53. PubMed ID: 8921052 [TBL] [Abstract][Full Text] [Related]
19. Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome. Toscani MK; Mario FM; Radavelli-Bagatini S; Spritzer PM Nutr Res; 2011 Feb; 31(2):97-103. PubMed ID: 21419313 [TBL] [Abstract][Full Text] [Related]
20. Serum leptin levels in premature pubarche and prepubertal girls with and without obesity. Teixeira RJ; Ginzbarg D; Rodrigues Freitas J; Fucks G; Silva CM; Bordallo MA J Pediatr Endocrinol Metab; 2004 Oct; 17(10):1393-8. PubMed ID: 15526717 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]